Results 91 to 100 of about 273,364 (223)

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

New England Journal of Medicine, 2015
BACKGROUND Effective treatment for hepatitis C virus (HCV) in patients coinfected with human immunodeficiency virus type 1 (HIV-1) remains an unmet medical need.
S. Naggie, C. Cooper, M. Saag, K. Workowski, P. Ruane, W. Towner, K. Marks, A. Luetkemeyer, R. Baden, P. Sax, E. Gane, Jorge Santana-Bagur, L. Stamm, Jenny C. Yang, P. German, H. Dvory‐Sobol, Liyun Ni, P. Pang, J. Mchutchison, C. Stedman, J. Morales-Ramirez, N. Bräu, D. Jayaweera, A. Colson, P. Tebas, D. Wong, D. Dieterich, M. Sulkowski   +27 more
semanticscholar   +1 more source

The prevalence of positive rapid diagnostic test of hepatitis C virus infection in Ghana

The Pan African Medical Journal, 2020
INTRODUCTION: HCV infection is one of the most common viral hepatitis in Africa. Rapid diagnostic test (RDT) is a useful tool to identify antibody anti-HCV in point of care.
Masood Maleki Birjandi, Mahbobeh Oroei
doaj   +1 more source

Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay

Journal of Infectious Diseases, 2018
Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of active infection in a single visit. This study evaluated the sensitivity and specificity of the Xpert HCV Viral Load Finger-Stick assay (Xpert HCV VL FS) for HCV RNA
F. Lamoury, S. Bajis, B. Hajarizadeh, A. Marshall, M. Martinello, Elena Ivanova, Beth Catlett, Y. Mowat, P. Marks, J. Amin, Julie Smith, N. Ezard, Victoria Cock, J. Hayllar, D. Persing, M. Kleman, P. Cunningham, G. Dore, T. Applegate, J. Grebely   +19 more
semanticscholar   +1 more source

Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.

Gastroenterology, 2015
BACKGROUND & AIMS Patients with detectable hepatitis C virus (HCV) RNA at the time of liver transplantation universally experience recurrent HCV infection.
Michael P. Curry, X. Forns, Raymond T. Chung, N. Terrault, Robert S. Brown, J. Fenkel, F. Gordon, O. Jacqueline, Leary, A. Kuo, T. Schiano, G. Everson, E. Schiff, A. Befeler, E. Gane, S. Saab, J. Mchutchison, G. Subramanian, W. Symonds, J. Denning, L. Mcnair, S. Arterburn, E. Svarovskaia, D. Moonka, N. Afdhal   +24 more
semanticscholar   +1 more source

A Markov model for the spread of Hepatitis C [PDF]

arXiv, 2008
We propose a Markov model for the spread of Hepatitis C virus (HCV) among drug users who use injections. We then proceed to an asymptotic analysis (large initial population) and show that the Markov process is close to the solution of a non linear autonomous differential system.
arxiv  

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).

Clinical Infectious Diseases, 2016
BACKGROUND Shortening the duration of treatment with HCV direct-acting antivirals (DAAs) leads to substantial cost reductions. According to the label, sofosbuvir and ledipasvir can be prescribed for 8 weeks (SL8) in noncirrhotic women or men with HCV ...
P. Ingiliz, S. Christensen, Torben Kimhofer, D. Hueppe, T. Lutz, K. Schewe, H. Busch, G. Schmutz, M. Wehmeyer, C. Boesecke, K. Simon, F. Berger, J. Rockstroh, J. Schulze zur Wiesch, A. Baumgarten, S. Mauss   +15 more
semanticscholar   +1 more source

Modeling the dynamics of Hepatitis C Virus with combined antiviral drug therapy: Interferon and Ribavirin [PDF]

arXiv, 2011
A mathematical modeling of Hepatitis C Virus (HCV) dynamics has been presented in this paper. The proposed model, which involves four coupled ordinary differential equations, describes the interaction of target cells (hepatocytes), infected cells, infectious virions and non-infectious virions.
arxiv  

Impact of a treatment as prevention strategy on hepatitis C virus transmission and on morbidity in people who inject drugs [PDF]

arXiv, 2015
Background: Highly effective direct-acting antiviral (DAA) regimens (90% efficacy) are becoming available for hepatitis C virus (HCV) treatment. This therapeutic revolution leads us to consider possibility of eradicating the virus. However, for this, an effective cascade of care is required.
arxiv  

Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study

International Journal of Circumpolar Health, 2019
Hepatitis C, caused by the hepatitis C virus (HCV), is a major public health issue in Russia. The aim of our study was to assess the seroprevalence of markers of HCV exposure and factors associated with HCV seropositivity among the general population ...
Tatiana Balaeva, Andrej M. Grjibovski, Olga Samodova, Anatoly Sannikov, Elise Klouman   +4 more
doaj   +1 more source

Hubble Catalog of Variables [PDF]

arXiv, 2017
The Hubble Catalog of Variables (HCV) project aims to identify the variable sources in the Hubble Source Catalog (HSC), which includes about 92 million objects with over 300 million measurements detected by the WFPC2, ACS and WFC3 cameras on board of the Hubble Space Telescope (HST), by using an automated pipeline containing a set of detection and ...
arxiv